Note 8 - Segment Information and Disaggregated Revenue (Tables)

6 Months Ended

Dec. 31, 2019

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

		Sales, Net						Segment
		U.S.		International				Gross					Capital
		Customers		Customers		Total		Profit (loss)			Depreciation		Expenditures
Contract Manufacturing	2019	$	11,501	$	2,303	$	13,804	$	1,927		$	69	$	43
	2018		10,498		1,258		11,756		1,246			66		269
Branded Proprietary Products	2019		2		-		2		(27	)		-		-
	2018		48		12		60		21			-		-
Other Nutraceutical Businesses	2019		375		16		391		126			-		-
	2018		181		4		185		63			-		-
Total Company	2019		11,878		2,319		14,197		2,026			69		43
	2018		10,727		1,274		12,001		1,330			66		269

		Sales, Net						Segment
		U.S.		International				Gross					Capital
		Customers		Customers		Total		Profit (Loss)			Depreciation		Expenditures
Contract Manufacturing	2019	$	20,502	$	4,286	$	24,788	$	3,177		$	159	$	101
	2018		19,153		2,455		21,608		2,328			131		287
Branded Proprietary Products	2019		4		10		14		(30	)		-		-
	2018		119		19		138		42			-		-
Other Nutraceutical Businesses	2019		752		49		801		278			1		-
	2018		520		39		559		179			1		-
Total Company	2019		21,258		4,345		25,603		3,425			160		101
	2018		19,792		2,513		22,305		2,549			132		287

Reconciliation of Assets from Segment to Consolidated [Table Text Block]

	Total Assets as of
	December 31,		June 30,
	2019		2019
Contract Manufacturing	$	18,017	$	17,580
Branded Proprietary Products
		395		427
Other Nutraceutical Businesses
		1,559		1,783
Total Company	$	19,971	$	19,790